Icl Israel Chemicals Stock Shares Outstanding
| ICL Stock | ILA 1,640 34.00 2.03% |
ICL Israel Chemicals fundamentals help investors to digest information that contributes to ICL Israel's financial success or failures. It also enables traders to predict the movement of ICL Stock. The fundamental analysis module provides a way to measure ICL Israel's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ICL Israel stock.
ICL |
ICL Israel Chemicals Company Shares Outstanding Analysis
ICL Israel's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current ICL Israel Shares Outstanding | 1.29 B |
Most of ICL Israel's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ICL Israel Chemicals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, ICL Israel Chemicals has 1.29 B of shares currently outstending. This is 109.87% higher than that of the Chemicals sector and significantly higher than that of the Materials industry. The shares outstanding for all Israel stocks is 125.45% lower than that of the firm.
ICL Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ICL Israel's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ICL Israel could also be used in its relative valuation, which is a method of valuing ICL Israel by comparing valuation metrics of similar companies.ICL Israel is currently under evaluation in shares outstanding category among its peers.
ICL Fundamentals
| Return On Equity | 0.43 | |||
| Return On Asset | 0.19 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.34 % | |||
| Current Valuation | 43.75 B | |||
| Shares Outstanding | 1.29 B | |||
| Shares Owned By Insiders | 44.90 % | |||
| Shares Owned By Institutions | 25.12 % | |||
| Price To Book | 2.00 X | |||
| Price To Sales | 3.31 X | |||
| Revenue | 6.96 B | |||
| Gross Profit | 2.61 B | |||
| EBITDA | 1.8 B | |||
| Net Income | 783 M | |||
| Cash And Equivalents | 492 M | |||
| Cash Per Share | 0.38 X | |||
| Total Debt | 2.44 B | |||
| Debt To Equity | 0.67 % | |||
| Current Ratio | 1.52 X | |||
| Book Value Per Share | 4.12 X | |||
| Cash Flow From Operations | 1.06 B | |||
| Earnings Per Share | 5.67 X | |||
| Price To Earnings To Growth | 168.10 X | |||
| Target Price | 9.13 | |||
| Number Of Employees | 12.5 K | |||
| Beta | 0.41 | |||
| Market Capitalization | 34.72 B | |||
| Total Asset | 11.08 B | |||
| Retained Earnings | 2.5 B | |||
| Working Capital | 939 M | |||
| Current Asset | 2.98 B | |||
| Current Liabilities | 2.05 B | |||
| Z Score | 8.4 | |||
| Annual Yield | 0.12 % | |||
| Five Year Return | 3.53 % | |||
| Net Asset | 11.08 B | |||
| Last Dividend Paid | 0.9 |
About ICL Israel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ICL Israel Chemicals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICL Israel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICL Israel Chemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in ICL Stock
When determining whether ICL Israel Chemicals is a strong investment it is important to analyze ICL Israel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ICL Israel's future performance. For an informed investment choice regarding ICL Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.